Teva Pharmaceutical Industries Ltd

TEVA

Company Profile

  • Business description

    Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.

  • Contact

    124 Dvora HaNeviā€™a Street
    Tel Aviv6944020
    ISR

    T: +972 39148213

    E: [email protected]

    https://www.tevapharm.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2025

    Employees

    35,686

Teva Pharmaceutical Industries Ltd News & Analysis

stocks

4 stocks in Buffett's portfolio

These undervalued stocks are among the holdings in Berkshire Hathaway today.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,004.7098.70-1.22%
CAC 407,988.9647.050.59%
DAX 4022,676.41347.641.56%
Dow JONES (US)41,350.9382.55-0.20%
FTSE 1008,521.4725.480.30%
HKSE23,564.77217.37-0.91%
NASDAQ17,648.45212.351.22%
Nikkei 22537,166.94373.831.02%
NZX 50 Index12,217.86193.11-1.56%
S&P 5005,599.3027.230.49%
S&P/ASX 2007,786.20103.90-1.32%
SSE Composite Index3,367.834.10-0.12%

Market Movers